Table 5.
Ten-year CVD risk reflected by FRS among different levels of multiple inflammation indicators.
| Ten-year CVD risk | ||||||
|---|---|---|---|---|---|---|
| Men >10%/women >11% | Men >20%/women >22% | Both >30% | ||||
| N | % | N | % | N | % | |
| MHR | ||||||
| T1 | 632 | 25.7 | 156 | 6.4 | 22 | 0.9 |
| T2 | 757 | 31.1 | 202 | 8.3 | 31 | 1.3 |
| T3 | 1017 | 40.1 | 399 | 15.7 | 90 | 3.6 |
| p for trend | <0.001 | <0.001 | <0.001 | |||
| NLR | ||||||
| T1 | 682 | 27.9 | 198 | 8.1 | 32 | 1.3 |
| T2 | 820 | 32.7 | 246 | 9.8 | 44 | 1.8 |
| T3 | 904 | 36.6 | 313 | 12.7 | 67 | 2.7 |
| p for trend | <0.001 | <0.001 | <0.001 | |||
| SII | ||||||
| T1 | 782 | 31.6 | 232 | 9.4 | 36 | 1.5 |
| T2 | 784 | 31.7 | 254 | 10.3 | 55 | 2.2 |
| T3 | 840 | 34.0 | 321 | 13.0 | 79 | 3.2 |
| p for trend | 0.007 | 0.025 | <0.001 | |||
| SIRI | ||||||
| T1 | 597 | 24.2 | 156 | 6.3 | 21 | 0.9 |
| T2 | 848 | 33.0 | 242 | 9.4 | 48 | 1.9 |
| T3 | 961 | 40.4 | 359 | 15.1 | 74 | 3.1 |
| p for trend | <0.001 | <0.001 | <0.001 | |||
The detailed intervals of these indicators were as the following: (1) MHR, T1: ≤0.27; T2: 0.28–0.42; T3: ≥0.43; (2) NLR, T1: ≤1.47; T2: 1.48–2.08; T3: ≥2.09; (3) SII, T1: ≤282.63; T2: 282.64–427.34; T3: ≥427.38; (4) SIRI, T1: ≤0.61; T2: 0.62–1.03; T3: ≥1.04. CVD, cardiovascular disease; FRS, Framingham risk score; MHR, monocyte-to-high-density lipoprotein ratio; NLR, neutrophil-to-lymphocyte ratio; SII, systematic immune-inflammation index; SIRI, systemic inflammation response index; T, tertile.
Statistical significance was defined under two-tailed conditions.